Amid a spike in fresh cases due to the new Covid-19 variant Omicron, Adar Poonawalla, chief executive officer of vaccine major Serum Institute of India, has shared a meme video that shows how countries are fighting the emerging variant of the coronavirus. .
A meme video created by the US-based Johns Hopkins Bloomberg School of Public Health shows a boy (marked as Vaccine) fighting two men (marked as Delta and Omicron variants of Covid-19). As soon as Tika has won over one of the two males (Delta), the other (Omicron) moves on to the boy. To overcome Omicron, the boy then uses a booster dose of the vaccine.
Sharing the video, Poonawalla reacted saying, “What is happening here!”.
The United States extended the authorization of a COVID-19 vaccine booster to everyone 18 years of age and older, six months after the completion of its primary vaccination series in November. Pfizer and Moderna announced the Food and Drug Administration’s decision after at least 10 states had already started giving boosters to all adults.
Within the last 10 days, Omicron has become a major COVID-19 variant in the US. US infections have doubled since early November to more than 150,000 cases per day on a seven-day average, a . According to Reuters Due to this, the health system of some cities of America has also collapsed.
Read also: COVID-19 Virus Update: Is Omicron the Last Form of Worry?
In India too, the cases of omicron are increasing rapidly. Data from the Ministry of Health and Family Welfare shows that as per the latest figures, the total number of omicron cases in the country has risen to 236, with the majority of cases being reported in Maharashtra and Delhi.
Meanwhile, Novavax Inc.’s COVID-19 vaccine Covovax, manufactured by Serum Institute of India, is effective in generating an immune response against the Omicron variant, and an additional booster dose creates more immune resistance to the new variant. , the US biotechnology company said today, citing preliminary data from a study.
Novavax said the data was drawn from ongoing studies of its vaccine’s effectiveness in adolescents and as a booster. Novavax and its partner Serum Institute of India have agreed to send over 1.1 billion doses of Novavax’s vaccine, NVX-CoV2373, to Kovax.
Read also: Kovovax COVID vaccine made by Serum Institute triggers immune response to Omicron: Study
Never miss a story! Stay connected and informed with Mint.
download
Our App Now!!
,